News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Samer Al Hadidi: Prior Exposure to Belantamab Mafodotin with Idecabtagene Vicluecel in Multiple Myeloma
Samer Al Hadidi/LinkedIn
Mar 18, 2025, 10:01

Samer Al Hadidi: Prior Exposure to Belantamab Mafodotin with Idecabtagene Vicluecel in Multiple Myeloma

Samer Al Hadidi, Assistant professor at UAMS Myeloma Center, posted on LinkedIn about recent paper he and colleagues co-authored, titled “Prior Exposure to Belantamab Mafodotin Influences Outcomes with Idecabtagene Vicluecel in Patients with Multiple Myeloma” published on American Society of Hematology Blood Advances.

Authors: Bhavesh Mohan Lal, Marah Alzubi, Jawad Alrawabdeh, John D. Shaughnessy, Jr, Fenghuang Zhan, Eric R. Siegel, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, Frits van Rhee, Samer Al Hadidi

Samer Al Hadidi: Prior Exposure to Belantamab Mafodotin with Idecabtagene Vicluecel in Multiple Myeloma

“Check out recent work published American Society of Hematology Blood Advances.

Prior Exposure to Belantamab, Mafodotin Influences Outcomes with Idecabtagene ,Vicluecel in Patients with Multiple Myeloma.”

American Society of Hematology Blood Advances Bhavesh Mohan Lal cancer Carolina Schinke Eric R. Siegel Fenghuang Zhan Frits Van Rhee Jawad Alrawabdeh John D. Shaughnessy Jr Marah Alzubi Maurizio Zangari multiple myeloma OncoDaily Oncology Samer Al Hadidi Sharmilan Thanendrarajan
Special Coverage
Blog
Aug 3, 2025, 20:29
Al-Ola A Abdallah: 2nd Regional ‪2025 Immune Cell Effector Therapy Symposium Conference
Blog
Aug 3, 2025, 20:04
How the Latest Evidence Is Used in EGFR-Mutated NSCLC Treatment - NCODA
Blog
Aug 3, 2025, 19:45
Miguel Bronchud: Primary Tumor Surgery Lymphadenectomy?
Blog
Aug 3, 2025, 19:41
Hung Trinh: First-of-its-kind Clinical Trial - Reprogramming Stem Cells to Create Renewable Cancer-fighting T Cells
Insight
Aug 3, 2025, 19:32
Amol Akhade: Understanding the Hidden Rules of Trial Design
Blog
Aug 3, 2025, 19:26
Dewi Vernerey: The Results of the ASTER 70s Trial
Insight
Aug 3, 2025, 19:25
Patrick Hwu։ Why Do Some Gastrointestinal Cancers Become Resistant to KRAS-targeted Therapies?
Insight
Aug 3, 2025, 19:18
Wafaa M Rashed: Polygenic Risk Score for Cancer in African Population
Insight
Aug 3, 2025, 18:54
Ali Mortezaei: Our Study on the Cover of the Journal of Neurosurgery Publishing Group Focus
Blog
Aug 3, 2025, 18:29
Bridging the Gap in the Diagnosis and Management of Lung Cancer - Hellenic Association of Lung Cancer
Blog
Aug 3, 2025, 18:27
Jyoti Bajpai: Behind Every Breakthrough in Cancer Care is a Doctor Who Dares to Look Beyond the Conventional
Blog
Aug 3, 2025, 18:15
City of Smile Charitable Foundation Has Been Named the Best Youth-Focused Healthcare Support Initiative